190 related articles for article (PubMed ID: 26020020)
1. Inclusion complexes of trihexyphenidyl with natural and modified cyclodextrins.
Maeda H; Tanaka R; Nakayama H
Springerplus; 2015; 4():218. PubMed ID: 26020020
[TBL] [Abstract][Full Text] [Related]
2. Effect of mechanochemical inclusion of triamterene into sulfobutylether-β-cyclodextrin and its improved dissolution behavior.
Maeda H; Shiobara R; Tanaka M; Kajinami A; Nakayama H
Drug Dev Ind Pharm; 2021 Apr; 47(4):535-541. PubMed ID: 33185132
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
Spamer E; Müller DG; Wessels PL; Venter JP
Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
[TBL] [Abstract][Full Text] [Related]
6. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
7. Propyl gallate/cyclodextrin supramolecular complexes with enhanced solubility and radical scavenging capacity.
Li Q; Pu H; Tang P; Tang B; Sun Q; Li H
Food Chem; 2018 Apr; 245():1062-1069. PubMed ID: 29287323
[TBL] [Abstract][Full Text] [Related]
8. Characterization and In Vivo Antiangiogenic Activity Evaluation of Morin-Based Cyclodextrin Inclusion Complexes.
De Gaetano F; Margani F; Barbera V; D'Angelo V; Germanò MP; Pistarà V; Ventura CA
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765179
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
12. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine.
Furuishi T; Sekino K; Gunji M; Fukuzawa K; Nagase H; Endo T; Ueda H; Yonemochi E
Pharm Dev Technol; 2019 Apr; 24(4):479-486. PubMed ID: 30126299
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
Zhou Q; Wei X; Dou W; Chou G; Wang Z
Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives.
Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808
[TBL] [Abstract][Full Text] [Related]
17. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin, an efficient tool for trans-anethole encapsulation: chromatographic, spectroscopic, thermal and structural studies.
Kfoury M; Auezova L; Greige-Gerges H; Ruellan S; Fourmentin S
Food Chem; 2014 Dec; 164():454-61. PubMed ID: 24996357
[TBL] [Abstract][Full Text] [Related]
19. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
[TBL] [Abstract][Full Text] [Related]
20. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
